HET0016, a Selective Inhibitor of 20-Hete Synthesis, Decreases Pro-Angiogenic Factors and Inhibits Growth of Triple Negative Breast Cancer in Mice

PLoS ONE - United States
doi 10.1371/journal.pone.0116247
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Downregulation of RIP140 in Triple‑negative Breast Cancer Inhibits the Growth and Proliferation of Cancer Cells

Oncology Letters
Cancer ResearchOncology
2018English

20-Hete Inhibition by HET0016 Decreases the Blood–Brain Barrier Permeability and Brain Edema After Traumatic Brain Injury

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2018English

Nano-Targeted Delivery of Rad6/Translesion Synthesis Inhibitor for Triple Negative Breast Cancer Therapy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Fangjihuangqi Decoction Inhibits MDA‐MB‐231 Cell Invasion in Vitro and Decreases Tumor Growth and Metastasis in Triple‐negative Breast Cancer Xenografts Tumor Zebrafish Model

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2020English

Triple-Negative Breast Cancer

2018English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2018English

Suppression of KIF3A Inhibits Triple Negative Breast Cancer Growth and Metastasis by Repressing Rb‐E2F Signaling and EMT

Cancer Science
Cancer ResearchMedicineOncology
2020English

WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of microRNAs

Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy